Improved long-term survival in multiple myeloma up to the age of 80 years

被引：124

作者：

Kristinsson, S. Y. ^{[1
,2
,3
,4
]}

Anderson, W. F. ^{[5
]}

Landgren, O. ^{[6
]}

机构：

[1] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden

[2] Karolinska Inst, Stockholm, Sweden

[3] Univ Iceland, Fac Med, Reykjavik, Iceland

[4] Landspitali Natl Univ Hosp, Dept Hematol, Reykjavik, Iceland

[5] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA

[6] NCI, Multiple Myeloma Sect, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA

来源：

LEUKEMIA | 2014年 / 28卷 / 06期

关键词：

DEXAMETHASONE; LENALIDOMIDE;

D O I：

10.1038/leu.2014.23

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1346 / 1348

页数：4

共 16 条

[1]

[Anonymous], CANC INC SWED 2006

[2] Recent major improvement in long-term survival of younger patients with multiple myeloma [J].

Brenner, Hermann ;

Gondos, Adam ;

Pulte, Dianne .

BLOOD, 2008, 111 (05) :2521-2526

[3] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma [J].

Dimopoulos, Meletios ;

Spencer, Andrew ;

Attal, Michael ;

Prince, H. Miles ;

Harousseau, Jean-Luc ;

Dmoszynska, Anna ;

San Miguel, Jesus ;

Hellmann, Andrzej ;

Facon, Thierry ;

Foa, Robin ;

Corso, Alessandro ;

Masliak, Zvenyslava ;

Olesnyckyj, Marta ;

Yu, Zhinuan ;

Patin, John ;

Zeldis, Jerome B. ;

Knight, Robert D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2123-2132

[4]

FRITZ April., 2000, International Classification of Diseases for Oncology, V3rd, P240

[5] Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients [J].

Gay, Francesca ;

Larocca, Alessandra ;

Wijermans, Pierre ;

Cavallo, Federica ;

Rossi, Davide ;

Schaafsma, Ron ;

Genuardi, Mariella ;

Romano, Alessandra ;

Liberati, Anna Marina ;

Siniscalchi, Agostina ;

Petrucci, Maria T. ;

Nozzoli, Chiara ;

Patriarca, Francesca ;

Offidani, Massimo ;

Ria, Roberto ;

Omede, Paola ;

Bruno, Benedetto ;

Passera, Roberto ;

Musto, Pellegrino ;

Boccadoro, Mario ;

Sonneveld, Pieter ;

Palumbo, Antonio .

BLOOD, 2011, 117 (11) :3025-3031

[6] A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma [J].

Jakubowiak, Andrzej J. ;

Dytfeld, Dominik ;

Griffith, Kent A. ;

Lebovic, Daniel ;

Vesole, David H. ;

Jagannath, Sundar ;

Al-Zoubi, Ammar ;

Anderson, Tara ;

Nordgren, Brian ;

Detweiler-Short, Kristen ;

Stockerl-Goldstein, Keith ;

Ahmed, Asra ;

Jobkar, Terri ;

Durecki, Diane E. ;

McDonnell, Kathryn ;

Mietzel, Melissa ;

Couriel, Daniel ;

Kaminski, Mark ;

Vij, Ravi .

BLOOD, 2012, 120 (09) :1801-1809

[7] Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003 [J].

Kristinsson, Sigurdur Yngvi ;

Landgren, Ola ;

Dickman, Paul W. ;

Derolf, Asa Rangert ;

Bjorkholm, Magnus .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1993-1999

[8] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients [J].

Kumar, S. K. ;

Dispenzieri, A. ;

Lacy, M. Q. ;

Gertz, M. A. ;

Buadi, F. K. ;

Pandey, S. ;

Kapoor, P. ;

Dingli, D. ;

Hayman, S. R. ;

Leung, N. ;

Lust, J. ;

McCurdy, A. ;

Russell, S. J. ;

Zeldenrust, S. R. ;

Kyle, R. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2014, 28 (05) :1122-1128

[9] Improved survival in multiple myeloma and the impact of novel therapies [J].

Kumar, Shaji K. ;

Rajkumar, S. Vincent ;

Dispenzieri, Angela ;

Lacy, Martha Q. ;

Hayman, Suzanne R. ;

Buadi, Francis K. ;

Zeldenrust, Steven R. ;

Dingli, David ;

Russell, Stephen J. ;

Lust, John A. ;

Greipp, Philip R. ;

Kyle, Robert A. ;

Gertz, Morie A. .

BLOOD, 2008, 111 (05) :2516-2520

[10] Treating myeloma: the future is already here! [J].

Landgren, Ola ;

Korde, Neha .

BLOOD, 2012, 120 (09) :1754-1756

← 1 2 →